Training for Ophthalmic Use of Strontium-90

Except as provided in 105 CMR 120.528, the licensee shall require an authorized user of a strontium-90 source for ophthalmic uses authorized under 105 CMR 120.559 to be a physician who: (A) Is an authorized user under 105 CMR 120.566 or equivalent Agreement State or Nuclear Regulatory Commission requirements; or (B)(1) Has completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include: (a) Radiation physics and instrumentation; (b) Radiation protection; (c) Mathematics pertaining to the use and measurement of radioactivity; and (d) Radiation biology; and (2) Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user who meets the requirements in 105 CMR 120.566 or 120.567, and that includes the use of strontium-90 for ophthalmic treatment of five individuals that includes: (a) Examination of each individual to be treated; (b) Calculation of the dose to be administered; (c) Administration of the dose; and (d) Follow-up and review of each individual’s case history; and (3) Has obtained written attestation, signed by a preceptor authorized user, who meets the requirements in 105 CMR 120.528, 120.566, 120.567 or equivalent Agreement State or Nuclear Regulatory Commission requirements, that the individual has satisfactorily completed the requirements in 105 CMR 120.567(B)(1) and (2) and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use. SEALED SOURCES FOR DIAGNOSIS